Masimo (MASI) Q1 Earnings and Revenues Surpass Estimates

Company Performance - Masimo reported quarterly earnings of $1.36 per share, exceeding the Zacks Consensus Estimate of $1.24 per share, and up from $0.77 per share a year ago, representing an earnings surprise of 9.68% [1] - The company posted revenues of $372 million for the quarter ended March 2025, surpassing the Zacks Consensus Estimate by 1.29%, but down from $492.8 million year-over-year [2] - Over the last four quarters, Masimo has consistently surpassed consensus EPS and revenue estimates [2] Future Outlook - The sustainability of Masimo's stock price movement will depend on management's commentary during the earnings call and future earnings expectations [3][4] - The current consensus EPS estimate for the upcoming quarter is $1.27 on revenues of $372.12 million, and for the current fiscal year, it is $5.28 on revenues of $1.52 billion [7] - The estimate revisions trend for Masimo is currently favorable, leading to a Zacks Rank 2 (Buy) for the stock, indicating expected outperformance in the near future [6] Industry Context - The Medical - Instruments industry, to which Masimo belongs, is currently ranked in the top 25% of over 250 Zacks industries, suggesting a positive outlook for stocks within this sector [8] - Empirical research indicates a strong correlation between near-term stock movements and trends in earnings estimate revisions, which can be tracked by investors [5]